BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program for substance abuse that includes peer recovery support; and distributes UnCraveRx weight loss management program, a medically assisted weight management program. The company is also developing BICX101, an injectable and implantable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Metrics to compare | BICX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBICXPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.8x | −1.6x | −0.6x | |
PEG Ratio | −0.12 | −0.04 | 0.00 | |
Price / Book | −0.3x | 1.1x | 2.6x | |
Price / LTM Sales | 99.1x | 0.9x | 3.2x | |
Upside (Analyst Target) | - | 50.8% | 43.9% | |
Fair Value Upside | Unlock | 15.1% | 7.8% | Unlock |